Cargando…
Dynamic Change of VOR and Otolith Function in Intratympanic Gentamicin Treatment for Ménière's Disease: Case Report and Review of the Literature
Intratympanic gentamicin treatment (IGT) is an evidence-based therapeutic option for recurrent vertigo attacks in Ménière's disease (MD). Today, in MD it is possible to monitor changes of vestibular receptor function, induced by IGT, with objective test methods such as the video head impulse te...
Autores principales: | Walther, L. E., Huelse, R., Blättner, K., Bloching, M. B., Blödow, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600330/ https://www.ncbi.nlm.nih.gov/pubmed/23533884 http://dx.doi.org/10.1155/2013/168391 |
Ejemplares similares
-
Intratympanic gentamicin for Ménière’s disease
por: Webster, Katie E, et al.
Publicado: (2023) -
Efficacy and Durability of Intratympanic Gentamicin Treatment for Meniere's Disease
por: Guan, Yafeng, et al.
Publicado: (2021) -
Intratympanic Gentamicin for Intractable Ménière's Disease – A Review and Analysis of Audiovestibular Impact
por: Yetişer, Sertaç
Publicado: (2018) -
Intratympanic corticosteroids for Ménière’s disease
por: Webster, Katie E, et al.
Publicado: (2023) -
One-shot, low-dosage intratympanic gentamicin for Ménière's disease: Clinical, posturographic and vestibular test findings
por: Daneshi, Ahmad, et al.
Publicado: (2014)